(11) 98705-3426
TrademarkIQ íconeTrademarkIQ
Voltar para busca
Dado oficial do USPTO

CAPNOPHARM

Sabia que essa marca já está registrada no Estados Unidos?

Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.

Active USPTO registrationTipo: VerbalEscritório: US

Snapshot rápido

CAPNOPHARM

ST13

US500000079269046

Classe

5, 10, 42, 44

Pedido

79269046

Registro

6126980

Diagnóstico de risco e oportunidade

Leitura executiva para decisão de naming, protocolo e monitoramento.

Atenção: há risco ativo

Situação USPTO

Active USPTO registration

Tipo de processo

Pedido e registro

Eventos registrados

39

Atualização mais recente

29/07/2026

Classificação

Registrada

Tipo de marca

Verbal

Classes Nice

5, 10, 42, 44

Data de depósito

24/07/2019

Data de registro

18/08/2020

Data de expiração

-

Ação recomendada

Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.

Próximo passo

Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.

Dados completos do processo

Campos estruturados da autoridade responsável e do histórico oficial.

Data da situação

29/07/2026

Última transação

29/07/2026

Escritório responsável

United States Patent and Trademark Office

Código da situação

708

Cadastro oficial

Principal Register

Código do desenho

4

Tipo de titular

99

Localização do titular

Tübingen, DE

Examinador

BLAZICH, JOAN MICHELE

Localização atual

Historical data usage

Titulares e representantes

Titulares

Capnopharm GmbH
Capnomed GmbH

Representantes

John J. Arnott Munck Wilson Mandala, LLP

Classificação técnica

Classes Nice

Classe 5Classe 10Classe 42Classe 44

Códigos Vienna

Sem códigos Vienna disponíveis.

Produtos e serviços

Classe 5

Medicines and drugs for use in oncology and for the prevention and treatment of immune system related diseases and disorders; Medicines and drugsanalgesic preparationsmedical and pharmaceutical preparations and substances for treatments in the field of oncology and palliative medicinepharmaceutical preparations for use in oncology

Classe 10

Medical apparatusinstruments and tools in the nature of surgical apparatusinstruments and tools for minimally invasive surgerytrocarsmedical tubes and air hoses for applying medical substances during minimally invasive surgery and automatic valves being structural parts for the aforesaid medical apparatus; metering pumps and injectors for administering medicines in aerosol form in measured amounts for medical purposes; structural components and accessories for aforesaid goods

Classe 42

Medical and pharmaceutical research and development services; scientific research for medical purposes in the field of oncology and palliative medicine

Classe 44

Medical consultancy in relation to medical apparatusinstruments and tools for minimally invasive surgery; medical services in relation to surgical proceduresminimally invasive surgical proceduresdiagnosistreatments and therapies in the field of oncology and palliative medicine; compilation of medical treatments and therapiesproviding of medical information in the field of oncology and palliative care; medical counseling in relation to aforesaid medical services; rental of medical apparatusinstruments and tools for minimally invasive surgery

Publicações

Histórico de despachos e eventos da marca no USPTO.

39 publicações encontradas

NA75

NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED

29/07/2026

C75P

REGISTERED - PARTIAL SEC. 71 ACCEPTED & SEC. 15 ACK.

29/07/2026

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

27/07/2026

ES75

TEAS SECTION 71 & 15 RECEIVED

13/04/2026

REM3

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED

18/08/2025

NREP

NEW REPRESENTATIVE AT IB RECEIVED

18/11/2023

CHLD

CHANGE OF OWNER RECEIVED FROM IB

30/09/2022

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

26/12/2020

FICS

FINAL DISPOSITION NOTICE SENT TO IB

07/12/2020

FIMP

FINAL DISPOSITION PROCESSED

07/12/2020

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

18/11/2020

R.PR

REGISTERED-PRINCIPAL REGISTER

18/08/2020

GPNX

NOTIFICATION PROCESSED BY IB

12/06/2020

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

02/06/2020

PUBO

PUBLISHED FOR OPPOSITION

02/06/2020

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

27/05/2020

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

27/05/2020

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

13/05/2020

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

29/04/2020

ALIE

ASSIGNED TO LIE

28/04/2020

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

22/04/2020

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

17/04/2020

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

17/04/2020

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

17/04/2020

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

16/04/2020

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

16/04/2020

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

16/04/2020

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

16/04/2020

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

16/04/2020

NREP

NEW REPRESENTATIVE AT IB RECEIVED

20/12/2019

RFNT

REFUSAL PROCESSED BY IB

22/11/2019

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

05/11/2019

RFRR

REFUSAL PROCESSED BY MPU

05/11/2019

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

20/10/2019

CNRT

NON-FINAL ACTION WRITTEN

19/10/2019

MAFR

APPLICATION FILING RECEIPT MAILED

15/10/2019

DOCK

ASSIGNED TO EXAMINER

14/10/2019

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

11/10/2019

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

10/10/2019

Proteção contínua da sua marca

Seja avisado a cada novo depósito que ameace CAPNOPHARM ou a sua marca.

Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.